clofarabine has been researched along with Myelomonocytic Leukemia, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corey, SJ; Elopre, M; Goldman, FD; Robinson, LJ; Rumelhart, S; Rytting, ME; Weitman, S | 1 |
1 other study(ies) available for clofarabine and Myelomonocytic Leukemia, Chronic
| Article | Year |
|---|---|
Complete remission following clofarabine treatment in refractory juvenile myelomonocytic leukemia.
Topics: Adenine Nucleotides; Antineoplastic Agents; Arabinonucleosides; Bone Marrow Transplantation; Child; Clofarabine; Drug Resistance, Neoplasm; Humans; Leukemia, Myelomonocytic, Chronic; Male; Neoplasm Recurrence, Local; Remission Induction; Treatment Outcome | 2005 |